NUS Enterprise Value Over E B I T D A from 2010 to 2024
| NUS Stock | USD 7.22 0.08 1.10% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 9.56472286 | Current Value 11.06 | Quarterly Volatility 2.0007797 |
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 26.4 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0844 or PTB Ratio of 1.12. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
NUS | Enterprise Value Over E B I T D A |
Latest Nu Skin's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Nu Skin Enterprises over the last few years. It is Nu Skin's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
NUS Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 9.11 | |
| Geometric Mean | 8.90 | |
| Coefficient Of Variation | 21.95 | |
| Mean Deviation | 1.52 | |
| Median | 9.00 | |
| Standard Deviation | 2.00 | |
| Sample Variance | 4.00 | |
| Range | 7.5067 | |
| R-Value | 0.13 | |
| Mean Square Error | 4.24 | |
| R-Squared | 0.02 | |
| Significance | 0.64 | |
| Slope | 0.06 | |
| Total Sum of Squares | 56.04 |
NUS Enterprise Value Over E B I T D A History
About Nu Skin Financial Statements
Nu Skin shareholders use historical fundamental indicators, such as Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 9.56 | 11.06 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.